Rhonda Patrick· PhD
Microdosing GLP-1 drugs—a solution for carb cravings?
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
Microdosing GLP-1 drugs—a solution for carb cravings?
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
and the intriguing potential of microdosing.
So maybe we do have that common ground is the dose. So with regards to GLP-1 at the risk of seeing everything through a singular lens, one of the most common variables that predicts longevity within families, there's one paper that actually mentions the word of of familial longevity.